Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study
暂无分享,去创建一个
Oguzhan Alagoz | Ann G Zauber | Iris Lansdorp-Vogelaar | Mehmet Ali Ergun | Brian L Sprague | Amy Trentham-Dietz | Carolyn M Rutter | Stephen Sy | A. Zauber | Chyke A Doubeni | C. Rutter | A. Tosteson | A. Trentham-Dietz | I. Lansdorp-Vogelaar | R. Meester | O. Alagoz | N. Stout | D. Corley | M. Ergun | B. Sprague | Jane J. Kim | Anna N A Tosteson | Jane J Kim | Reinier G S Meester | Emily A Burger | Nicole G Campos | Natasha Stout | Douglas A Corley | E. Burger | S. Sy | N. Campos
[1] Donald L Weaver,et al. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. , 2015, Journal of the National Cancer Institute.
[2] D. Cutter,et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials , 2012, The Lancet.
[3] M. Manos,et al. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[4] M. Phipps,et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.
[5] Allan Hildesheim,et al. An updated natural history model of cervical cancer: derivation of model parameters. , 2014, American journal of epidemiology.
[6] Christopher D. Jensen,et al. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[7] Eric J Feuer,et al. Secular trends in colon and rectal cancer relative survival. , 2013, Journal of the National Cancer Institute.
[8] Carolyn M. Rutter,et al. Clarifying Differences in Natural History between Models of Screening , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[9] J. Haas,et al. Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium. , 2016, JAMA.
[10] T. Wilt,et al. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.
[11] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[12] D. Ransohoff,et al. Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.
[13] Sarah E Lillie,et al. Organizational Predictors of Colonoscopy Follow-up for Positive Fecal Occult Blood Test Results: An Observational Study , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[14] E. Halm,et al. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[15] Eric J Feuer,et al. Dynamic Microsimulation Models for Health Outcomes , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[16] Angela Mariotto,et al. Cancer Intervention and Surveillance Modeling Network (CISNET) , 2001, Journal of Investigative Medicine.
[17] Tracey L Marsh,et al. Validation of Models Used to Inform Colorectal Cancer Screening Guidelines , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.
[18] T. Holford,et al. The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age–Period–Cohort Model , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[19] P. Castle,et al. Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] Natasha K. Stout,et al. Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model , 2006 .
[21] B. Monsees,et al. The Mammography Quality Standards Act. An overview of the regulations and guidance. , 2000, Radiologic clinics of North America.
[22] Jasmin A. Tiro,et al. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium , 2016, Journal of General Internal Medicine.
[23] J. Cuzick,et al. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis. , 2015, Annals of internal medicine.
[24] J. Habbema,et al. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. , 2014, Annals of internal medicine.
[25] V. Moyer,et al. Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[26] Carolyn M Rutter,et al. An Evidence-Based Microsimulation Model for Colorectal Cancer: Validation and Application , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[27] Vipat Kuruchittham,et al. The Wisconsin Breast Cancer Epidemiology Simulation Model. , 2006, Journal of the National Cancer Institute. Monographs.
[28] Oguzhan Alagoz,et al. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies , 2016, Annals of Internal Medicine.
[29] J. Lortet-Tieulent,et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.
[30] T. Muto,et al. The evolution of cancer of the colon and rectum , 1975, Cancer.
[31] Oguzhan Alagoz,et al. Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis , 2013, Breast Cancer Research and Treatment.